Quigley sales
This article was originally published in The Tan Sheet
Executive Summary
Cold-Eeze marketer spent $714,329 on cooperative advertising promotions during third quarter ended Sept. 30, more than triple the level spent in the year-ago period, 1Quigley's 10-Q says. Net sales rose 19.2% to $8.3 mil., with a net loss of $500,395, compared to net income of $313,615 in the year-ago period. Quigley is partnering with CDC to include educational materials about appropriate antibiotic use in Cold-Eeze samples sent to 7,000-8,000 healthcare providers by year end. Firm also intends to introduce one Cold-Eeze line extension in March 2003; honey lemon-flavored zinc lozenge, the line's most recent addition, began shipping in August (2"The Tan Sheet" Feb. 25, 2002, In Brief)...
You may also be interested in...
Quigley “eezes” into profitability
Cold-Eeze marketer will add honey lemon flavor to zinc lozenge line in time for next cold season, firm says Feb. 19. All Cold-Eeze products will be promoted in the fall with six-week radio ad campaign; Quigley says it has shifted emphasis from broad-based media campaigns to more "efficient" programs, to which firm attributes recent strong earnings growth. For the year, Quigley reported revenues up 46.8% to $24.7 mil., with net income of $216,000 compared with a $5.2 mil. loss last year. Q4 revenue rose 19.7% to $8.5 mil.; net income inched up 2.7%...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.